Purpose. The purpose of our study was to retrospectively evaluate the feasibility, safety and effectiveness of microwave ablation (MWA) in nine patients with unresectable lung tumour. Materials and methods. Ten lesions were treated in ten ablation sessions in nine patients. The treatments were performed with a microwave generator with 45 W and 915 MHz connected to a 14.5-gauge antenna for 10 min. Antenna placement was performed with computed tomography (CT) fluoroscopy guidance or XperGuide. All patients underwent CT follow-up at 1, 3 and 6 months from the procedure. Results. Technical success was obtained in all cases; mortality at 30 days was 0%. Conclusions. This study shows that in selected patients, MWA is a valid alternative to other ablative techniques. Further studies are required to demonstrate the short-and long-term effects of this technique and to make a comparison with other available ablation systems, especially with radiofrequency. Radiol med (2010) 115:962-974 
Introduction
Surgery is still the treatment of choice for non-small-cell lung cancer (NSCLC) [1, 2] . However, only 20% of all diagnosed NSCLCs are resectable [1, 2] . This has prompted the development of alternatives to surgical treatment, such as ablation techniques, to enable local control of unresectable tumours [3, 4] . Over the years, various ablation techniques have been developed, including ethanol ablation, laser ablation, cryoablation and radiofrequency ablation (RFA) [3, 4] . The most widely used technique is radiofrequency ablation [5] [6] [7] [8] [9] [10] [11] [12] .
Microwave ablation (MWA) therapy is a relatively new technique that can be applied to different types of tumours. It is able to offer all the benefits of RFA as well as some substantial advantages. These include larger volumes of cellular necrosis, reduced procedure times, greater temperatures delivered to the target lesion, the possibility of the simultaneous use of multiple antennae, efficacy on lesions with cystic components and/or in proximity to vascular structures >3 mm in diameter with a reduction in the heat-sink effect, and less intraprocedural pain [5, 6, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] .
In the radiation spectrum, microwaves lie between infrared and radio waves, with a frequency between 900 and 2,450 MHz [6] . Microwaves induce the oscillation of water molecules at a speed between 2 and 5 billion times per second, depending on the frequency of the microwaves themselves [5, 6, 16, 17] . Cell death is produced by thermocoagulation and necrosis as a result of the heat generated by oscillations of ions induced by the microwaves, the degree of which is proportional to the intensity and frequency of the microwaves themselves [6, 7] . The aim of this study was to demonstrate the technical success, safety and efficacy of MWA in nine patients affected by unresectable lung cancer.
Materials and methods

Patients
This retrospective study was approved by the ethics committee of our centre. Nine patients (seven men, two women) with a mean age of 78 (range 69-88) years who underwent percutaneous MWA of ten intraparenchymal pulmonary masses (mean 1.1 lesions per patient) in ten ablation sessions between 26 November 2008 and 12 August 2009 were enrolled in the study (Table 1 ). All selected patients had neoplastic disease that was judged to be inoperable on the basis of tumour stage, comorbidities, advanced age and/or refusal to undergo surgery. Indication, risks and benefits of the procedure
Introduzione
La terapia chirurgica rimane il trattamento di scelta per il carcinoma polmonare non a piccole cellule (NSCLC) [1, 2] . Tuttavia, solo il 20% di tutti i NSCLC diagnosticati risulta essere chirurgicamente resecabile [1, 2] Ciò ha pertanto spinto verso la ricerca di metodi alternativi al trattamento chirurgico, quali le tecniche ablative, per consentire il controllo locale di tumori non resecabili [3, 4] . Nel corso degli anni sono state sviluppate diverse tecniche ablative: ablazione con etanolo, laserablazione, crioablazione e termoablazione mediante radiofrequenza (RFA) [3, 4] . Attualmente la metodica più diffusamente impiegata nella pratica clinica è la radiofrequenza [5] [6] [7] [8] [9] [10] [11] [12] .
La [5, 6, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] .
Nello spettro delle radiazioni le microonde si collocano tra le radiazioni infrarosse e le radioonde con una frequenza tra 900 e 2450 MHz [6] . Le microonde, inducendo l'oscillazione delle molecole d'acqua con movimenti di rotazione su se stesse in avanti ed indietro ad una velocità di 2-5 miliardi di volte al secondo dipendente dalla frequenza delle onde stesse [5, 6, 16, 17] . La morte cellulare avviene attraverso necrosi termocoagulativa grazie al calore generato dall'oscillazione degli ioni indotta dalle microonde in proporzione all'intensità ed alla frequenza delle onde stesse [6, 7] . Lo scopo dello studio è stato quello di dimostrarare il successo tecnico, la sicurezza, l'efficacia della metodica del trattamento ablativo mediante MW in 9 pazienti affetti da neoplasia polmonare non trattabile chirurgicamente. 
Materiali e metodi
Baseline imaging
Pretreatment imaging consisted of a thoracic multidetectorrow computed tomography (MDCT) scan extending to the abdomen (Aquilion 64, Toshiba, Japan) with and without contrast administration. Each MDCT scan was acquired with a thickness of 0.5 mm, voltage of 120 kV and tube current of 250 mA. The contrast-enhanced scans were acquired after injection of 100 ml of iodinated contrast agent (Visipaque 320, GE Healthcare, USA) at an injection rate of 3 ml/s, followed by injection of 40 ml saline at a rate of 2 ml/s. One week prior to the ablation treatment, all patients underwent percutaneous pulmonary biopsy under CT guidance, with histological confirmation of NSCLC for all lesions.
Pretreatment procedure
Before the beginning of each procedure, local anaesthesia of the antenna entrance site was achieved with subcutaneous injection of a 10-ml solution of 2% Carbocaine. Each patient was kept in a state of moderate sedation through intravenous administration of a combination of midazolam (0.07-0.08 mg/kg), propofol (0.5-2.0 mg/kg/h) and fentanyl (1-2 µg/kg). Heart rate, electrocardiographic trace, oxygen saturation, respiratory frequency and blood pressure were continuously monitored throughout the procedure. During the entire ablation session, patients were monitored by an anaesthetist. Adequate antibiotic prophylaxis was achieved with intravenous administration of 1 g of cefazolin sodium (Ancef, SmithKline Beecham Pharmaceuticals, Philadelphia, USA) given every 8 h for 24 h, beginning shortly before the procedure.
Equipment
Imaging guidance
In eight out of ten sessions (7/10 lesions), the antenna was placed under CT fluoroscopy guidance, whereas in the remaining two sessions (3/10 lesions), the procedure was performed with XperGuide. The choice of imaging guidance was made on a random basis.
Microwave equipment and percutaneous microwave ablation procedure
An ablation system was used comprising a microwave generator (Evident Microwave Ablation System, Covidien Ltd) capable of producing 45 W at 915 MHz, connected by coaxial cable to a 14.5-gauge straight microwave antenna with a 3.7-cm radiating section. The antennae were continuously perfused with saline solution at room temperature at 60 ml/min to avoid possible thermal damage along the prox- were treated with a single antenna, whereas in lesions with a maximum diameter >3 cm (2/10 lesions) two antennae were simultaneously positioned at a distance of 1 cm from each other to achieve adequate necrosis. Upon completion of the procedure, whether performed with CT fluoroscopic guidance or XperGuide, technical success was checked with CT fluoroscopy. After ablation, patients were transferred to the radiology recovery room for observation. At 2 h from the procedure, each patient underwent chest radiography to evaluate the presence of immediate complications.
Follow-up
All patients underwent CT follow-up with and without contrast administration at 1, 3 and 6 months in combination with complete blood and metabolic tests. All CT scans were acquired with 0.5-mm thickness, 120 kV and 250 mA. The contrast-enhanced scans were obtained after administration of 100 ml of iodinated contrast agent (Visipaque 320, GE Healthcare) injected at a rate of 3 ml/s, followed by 40 ml of saline solution at a rate of 2 ml/s. The following imaging characteristics were evaluated: maximum postablation diameter of the mass; presence of cavitation; absent lesion enhancement (<15 HU); pleural effusion; adenopathy (short axis >1 cm); total volume of the ablated area (calculated with volume analysis software, Vitrea 2, software 3.8, Vital Images Inc, Minnesota, USA).
Outcomes: technical success, safety and efficacy of the technique Technical success was defined as the correct positioning of the antennae within the lesion. Safety was defined as the frequency of intra-, peri-and postprocedural complications [6] . All complications were recorded and classified as major or minor in accordance with the classification system of the Society of Interventional Radiology [23] . All patients were evaluated for the presence of postablation syndrome [24] . Pain was evaluated on the basis of a visual analogue scale (VAS) [25] . The effectiveness of the technique was defined as complete absence of enhancement (HU <15) within the ablation zone on contrast-enhanced CT images [13] .
Results
Tumours were measured in the three dimensions obtaining a mean index of the maximum diameter of 29.5 mm (range 14-69 mm) ( Table 3) . In five cases, the masses were located in the right lung, with the remaining cases in the left lung. Histological analysis showed that all lesions were NSCLC: six squamous-cell pulmonary carcinomas, three adenocarcinomas and one neuroendocrine carcinoma ( [13] .
the tumours were metastases from primary pulmonary tumours located in the contralateral lung (stage IV, M1).
Technical success
Technical success was 100%. In all cases, the antenna was correctly placed within the lesion [6] .
Safety
No major complications were recorded in the intra-and periprocedural period. The 30-day postablation mortality rate was 0%. There was one death at 3 months of a 69-year-old male patient affected by stage IV neuroendocrine carcinoma of the left lobe caused by a combination of factors related to the systemic disease associated with comorbidities. The death was therefore only relatively related to the ablation therapy. Ablation therapy nonetheless produced complete necrosis of the mass in this patient. Asymptomatic grade 1 pneumothorax was recorded in three patients. There were no cases of symptomatic grade 2 pneumothorax, nor were there any cases of skin burns induced by microwave-related thermal damage [12, 21] . No patient was diagnosed with a postablation syndrome, had a VAS score indicating a need for pain relief, or patient required admission to an intensive care unit.
Efficacy
Efficacy 90%. Complete necrosis was observed in nine out of ten lesions.
Imaging characteristics of lesions during follow-up
CT fluoroscopy scans obtained in the periprocedural period showed the presence of tumour necrosis as a result of the thermal effect induced by the microwaves. A common finding was areas of ground-glass attenuation within the ablated lesion and extending to the areas around the antenna. Additional CT scans were performed at intervals of 1 (all patients), 3 (8/9 patients) and 6 months (3/9 patients).
After an initial increase of 0.67 cm in maximum diameters, there was a persistent reduction in diameter of the ablated areas at subsequent examinations, consistent with consolidation of the pulmonary parenchyma. During follow-up imaging, the presence of a cavitation was noted in 50% of cases (5/10 lesions) (Fig. 1) . Minor pleural effusions were found in 20% of cases (2/10 lesions). Adenopathies with maximum dimensions <1 cm were found at the level of the treated lesion in 10% of cases (1/10 lesions). Disease recurrence was detected at 3 months in one case. The patient underwent additional ablation treatment at 3 months from initial treatment, producing complete necrosis of the recurrent lesion (Fig. 2) 
Successo tecnico
Il successo tecnico è stato del 100%: in tutti i casi l'antenna è stata correttamente posizionata all'interno della lesione [6] . [12, 21] . Tutti i pazienti sono stati indagati in merito alla sindrome post-ablazione [23] . In questo studio in nessun paziente è stata diagnosticata sindrome post-ablazione. Nessun paziente ha espresso un valore, secondo il VAS score, tale da richiedere terapia antalgica. Nessun paziente ha necessitato il ricovero presso l'unità operativa di terapia intensiva.
Sicurezza
Non abbiamo riportato complicanze maggiori nel periodo intra-e peri-procedurale. Il tasso di mortalità a 30 giorni post-ablazione è stato dello 0%. A 3 mesi dal trattamento si è verificata morte in un paziente
Efficacia della metodica
L'efficacia della metodica è stata del 90%: è stata osservata una necrosi completa in 9 lesioni su 10.
Caratteristiche all'imaging delle lesioni durante il follow-up
Le scansioni fluoro-TC eseguite nell'immediato periodo peri-procedurale hanno dimostrato la presenza di necrosi several days after the procedure. The total follow-up period was recorded in all patients as the time from the date of the procedure to the most recent CT scan, with mean duration being 3.6 (range 1-9) months.
Discussion
Over the years, several ablation techniques have been developed for local control of unresectable tumours: ethanol ablation, laser ablation, cryoablation and radiofrequency ther- [3, 4] . The most widely used technique in clinical practice is RFA [5] . MWA is a relatively new technique that can be applied to different types of tumours and offers all the benefits of RFA as well as some substantial advantages. These include a larger volume of cellular necrosis, reduction in procedure times, greater temperatures delivered to the target lesion, the possibility of using multiple antennae simultaneously, efficacy on lesions with a cystic component and/or in proximity to vascular structures >3 mm in diameter with a reduction in the heat-sink effect, and less intraprocedural pain [5, 6, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . In addition, MWA does not require placement of grounding pads [5] . In RFA, direct tissue heating is confined to an area of only a few millimetres surrounding the active electrode, whereas heating of the remaining target zone takes place through simple thermal conduction [3, 5, 6, 17, 21, 26] . In contrast, microwaves induce oscillation of water molecules at a speed between 2 and 5 billion times per second, depending on the frequency of the microwaves themselves, thus producing a better convection profile and causing more uniform coagulation and necrosis of the target [5, 6, 15, 16, 21] . RFA is also limited by the increase in impedance, with boiling and charring of the tissue, due to vaporisation of water molecules that act as electrical insulators. As microwaves generate an electromagnetic wave electrically independent of the antenna, they do not seem to be subject to an increase in impedance, thanks to the nature of the waves themselves [2, 5, 6, 21, 27, 28] . The MWA system allows simultaneous placement of multiple antennae, each connected to its own generator, thus making possible areas of necrosis of [3, 4] . Attualmente la metodica più diffusamente impiegata nella pratica clinica è la radiofrequenza [5] . Le up to 6 cm and therefore exceeding the dimensional limitations of RFA [5, 6, 14, 21] . A comparison of the findings of our study with those reported in the literature with regard to RFA shows that the mean necrosis diameter obtained with microwaves is greater (mean diameter 3.5 cm) than with RFA (1.7 cm) [3, 29] . Even the study by Brace et al. and Durich et al. [20, 21] shows that mean diameter and mean transverse area of necrosis are greater with MWA than with RFA: mean diameter by 25% and mean transverse area by 50% (Table 4) . [5, 6, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Inoltre l'ablazione con MW non richiede il posizionamento di grounding pads [5] . Nelle ablazioni con radiofrequenze l'attività diretta di surriscaldamento dei tessuti è limitata ad una zona che circonda l'elettrodo attivo per soli pochi millimetri, mentre l'aumento della temperatura nella restante zona target avviene attraverso semplice conduzione termica [3, 5, 6, 17, 21, 32 [12] . Lo sviluppo di linfoadenopatia non è significativamente correlata al Table 4 Studies reporting microwave ablation (MWA) therapy of lung tumours
